Response to Anti-HER2-Based Treatment in a Patient with Bladder Adenocarcinoma Harboring HER2 Amplification and S310F Mutation Discovered by Next-Generation Sequencing: A Case Report

Response to Anti-HER2-Based Treatment in a Patient with Bladder Adenocarcinoma Harboring HER2 Amplification and S310F Mutation Discovered by Next-Generation Sequencing: A Case Report

Xiaolu Wang, Wenjing Hu, Li Xie The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing, People’s Republic of ChinaCorrespondence: Li Xie; Wenjing HuThe Comprehensive Cancer Centre of Drum Tower...

Full description

Bibliographic Details
Main Authors: Wang X, Hu W, Xie L
Format: Article
Language:English
Published: Dove Medical Press 2020-05-01
Series:OncoTargets and Therapy
Subjects:
bladder adenocarcinoma
human epidermal growth factor receptor 2
next-generation sequencing
trastuzumab
Online Access:https://www.dovepress.com/response-to-anti-her2-based-treatment-in-a-patient-with-bladder-adenoc-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/response-to-anti-her2-based-treatment-in-a-patient-with-bladder-adenoc-peer-reviewed-article-OTT

Similar Items